JPY 2808.0
(2.3%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 202.35 Billion JPY | 16.92% |
2022 | 173.06 Billion JPY | 20.08% |
2021 | 144.12 Billion JPY | 70.03% |
2020 | 84.76 Billion JPY | 2.88% |
2019 | 82.39 Billion JPY | 22.83% |
2018 | 67.07 Billion JPY | -5.78% |
2017 | 71.19 Billion JPY | 8.83% |
2016 | 65.41 Billion JPY | 8.47% |
2015 | 60.3 Billion JPY | 148.81% |
2014 | 24.23 Billion JPY | 8.43% |
2013 | 22.35 Billion JPY | 25.44% |
2012 | 17.82 Billion JPY | 24.94% |
2011 | 14.26 Billion JPY | 37.68% |
2010 | 10.36 Billion JPY | 140.5% |
2009 | 4.3 Billion JPY | 0.0% |
2008 | - JPY | 0.0% |
2007 | - JPY | -100.0% |
2006 | 750 Million JPY | -6.25% |
2005 | 800 Million JPY | -30.54% |
2004 | 1.15 Billion JPY | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 213.11 Billion JPY | 5.32% |
2023 Q4 | 202.35 Billion JPY | 3.15% |
2023 Q3 | 196.17 Billion JPY | 6.41% |
2023 FY | 202.35 Billion JPY | 16.92% |
2023 Q2 | 184.35 Billion JPY | 1.83% |
2023 Q1 | 181.05 Billion JPY | 4.62% |
2022 Q2 | 149.11 Billion JPY | 7.55% |
2022 Q3 | 146.33 Billion JPY | -1.87% |
2022 Q4 | 173.06 Billion JPY | 18.27% |
2022 FY | 173.06 Billion JPY | 20.08% |
2022 Q1 | 138.65 Billion JPY | -3.8% |
2021 Q2 | 79.67 Billion JPY | -1.7% |
2021 Q1 | 81.05 Billion JPY | -4.38% |
2021 FY | 144.12 Billion JPY | 70.03% |
2021 Q4 | 144.12 Billion JPY | 88.84% |
2021 Q3 | 76.32 Billion JPY | -4.21% |
2020 FY | 84.76 Billion JPY | 2.88% |
2020 Q1 | 98.31 Billion JPY | 19.32% |
2020 Q2 | 85.5 Billion JPY | -13.03% |
2020 Q3 | 84.24 Billion JPY | -1.48% |
2020 Q4 | 84.76 Billion JPY | 0.62% |
2019 FY | 82.39 Billion JPY | 22.83% |
2019 Q4 | 82.39 Billion JPY | 33.84% |
2019 Q3 | 61.56 Billion JPY | -1.77% |
2019 Q2 | 62.67 Billion JPY | -3.15% |
2019 Q1 | 64.71 Billion JPY | -3.53% |
2018 Q3 | 62.18 Billion JPY | -1.48% |
2018 Q4 | 67.07 Billion JPY | 7.86% |
2018 FY | 67.07 Billion JPY | -5.78% |
2018 Q1 | 64.37 Billion JPY | -9.58% |
2018 Q2 | 63.12 Billion JPY | -1.94% |
2017 Q1 | 58.29 Billion JPY | -10.89% |
2017 FY | 71.19 Billion JPY | 8.83% |
2017 Q4 | 71.19 Billion JPY | 7.03% |
2017 Q3 | 66.51 Billion JPY | 0.31% |
2017 Q2 | 66.31 Billion JPY | 13.75% |
2016 Q3 | 59.19 Billion JPY | -0.28% |
2016 FY | 65.41 Billion JPY | 8.47% |
2016 Q1 | 57.17 Billion JPY | -5.2% |
2016 Q4 | 65.41 Billion JPY | 10.5% |
2016 Q2 | 59.36 Billion JPY | 3.83% |
2015 Q1 | 32.11 Billion JPY | 32.5% |
2015 Q2 | 48.98 Billion JPY | 52.52% |
2015 Q3 | 48.88 Billion JPY | -0.21% |
2015 Q4 | 60.3 Billion JPY | 23.37% |
2015 FY | 60.3 Billion JPY | 148.81% |
2014 Q4 | 24.23 Billion JPY | 2.63% |
2014 Q3 | 23.61 Billion JPY | 19.17% |
2014 Q2 | 19.82 Billion JPY | -4.58% |
2014 FY | 24.23 Billion JPY | 8.43% |
2014 Q1 | 20.77 Billion JPY | -7.09% |
2013 Q2 | 16.05 Billion JPY | -3.75% |
2013 FY | 22.35 Billion JPY | 25.44% |
2013 Q3 | 20.67 Billion JPY | 28.73% |
2013 Q4 | 22.35 Billion JPY | 8.15% |
2013 Q1 | 16.68 Billion JPY | -6.39% |
2012 FY | 17.82 Billion JPY | 24.94% |
2012 Q4 | 17.82 Billion JPY | 4.7% |
2012 Q3 | 17.02 Billion JPY | -2.3% |
2012 Q2 | 17.42 Billion JPY | -4.76% |
2012 Q1 | 18.29 Billion JPY | 28.23% |
2011 FY | 14.26 Billion JPY | 37.68% |
2011 Q2 | 12.2 Billion JPY | -0.81% |
2011 Q3 | 12.45 Billion JPY | 2.05% |
2011 Q1 | 12.3 Billion JPY | 18.73% |
2011 Q4 | 14.26 Billion JPY | 14.57% |
2010 Q1 | 4 Billion JPY | -7.14% |
2010 Q4 | 10.36 Billion JPY | 15.11% |
2010 FY | 10.36 Billion JPY | 140.5% |
2010 Q2 | 9 Billion JPY | 125.0% |
2010 Q3 | 9 Billion JPY | 0.0% |
2009 FY | 4.3 Billion JPY | 0.0% |
2009 Q2 | 4 Billion JPY | 0.0% |
2009 Q3 | 4 Billion JPY | 0.0% |
2009 Q4 | 4.3 Billion JPY | 7.69% |
2009 Q1 | - JPY | 0.0% |
2008 Q4 | - JPY | 0.0% |
2008 FY | - JPY | 0.0% |
2008 Q3 | - JPY | 0.0% |
2007 FY | - JPY | -100.0% |
2006 FY | 750 Million JPY | -6.25% |
2005 FY | 800 Million JPY | -30.54% |
2004 FY | 1.15 Billion JPY | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 16.89 Billion JPY | -1098.011% |
Takeda Pharmaceutical Company Limited | 4843.75 Billion JPY | 95.822% |
Sumitomo Pharma Co., Ltd. | 418.88 Billion JPY | 51.692% |
Shionogi & Co., Ltd. | 11.62 Billion JPY | -1641.446% |
Wakamoto Pharmaceutical Co.,Ltd. | 100.52 Million JPY | -201191.17% |
Nippon Shinyaku Co., Ltd. | 2.87 Billion JPY | -6945.822% |
Kaken Pharmaceutical Co., Ltd. | 3.85 Billion JPY | -5156.0% |
Eisai Co., Ltd. | 206.74 Billion JPY | 2.123% |
Morishita Jintan Co., Ltd. | 425 Million JPY | -47513.176% |
Hisamitsu Pharmaceutical Co., Inc. | 2.1 Billion JPY | -9536.0% |
Mochida Pharmaceutical Co., Ltd. | 369 Million JPY | -54739.024% |
Fuso Pharmaceutical Industries,Ltd. | 12.72 Billion JPY | -1490.599% |
Nippon Chemiphar Co., Ltd. | 16.98 Billion JPY | -1091.661% |
Tsumura & Co. | 79.69 Billion JPY | -153.929% |
Kissei Pharmaceutical Co., Ltd. | 1.72 Billion JPY | -11617.197% |
Torii Pharmaceutical Co., Ltd. | 244 Million JPY | -82832.787% |
Fuji Pharma Co., Ltd. | 28.94 Billion JPY | -599.033% |
Zeria Pharmaceutical Co., Ltd. | 47.58 Billion JPY | -325.244% |
KYORIN Holdings, Inc. | 20.94 Billion JPY | -866.084% |
Taiko Pharmaceutical Co.,Ltd. | 3.8 Billion JPY | -5212.575% |
Daito Pharmaceutical Co.,Ltd. | 8.71 Billion JPY | -2220.862% |
SymBio Pharmaceuticals Limited | - JPY | -Infinity% |
MedRx Co., Ltd | - JPY | -Infinity% |
Mizuho Medy Co.,Ltd. | - JPY | -Infinity% |
Solasia Pharma K.K. | 60 Million JPY | -337160.0% |
Modalis Therapeutics Corporation | 412.5 Million JPY | -48956.0% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 9.48 Billion JPY | -2033.432% |
Sawai Group Holdings Co., Ltd. | 82.89 Billion JPY | -144.126% |
Cyfuse Biomedical K.K. | 913 Million JPY | -22063.855% |
Toho Holdings Co., Ltd. | 30.24 Billion JPY | -569.078% |
Koa Shoji Holdings Co.,Ltd. | 2.82 Billion JPY | -7062.314% |